PL3148517T3 - Kompozycje i sposoby do promowania tworzenia kości - Google Patents
Kompozycje i sposoby do promowania tworzenia kościInfo
- Publication number
- PL3148517T3 PL3148517T3 PL15799544T PL15799544T PL3148517T3 PL 3148517 T3 PL3148517 T3 PL 3148517T3 PL 15799544 T PL15799544 T PL 15799544T PL 15799544 T PL15799544 T PL 15799544T PL 3148517 T3 PL3148517 T3 PL 3148517T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- methods
- bone formation
- promote bone
- promote
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000011164 ossification Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462005359P | 2014-05-30 | 2014-05-30 | |
| PCT/US2015/032820 WO2015184059A1 (en) | 2014-05-30 | 2015-05-28 | Compositions and methods to promote bone formation |
| EP15799544.0A EP3148517B1 (en) | 2014-05-30 | 2015-05-28 | Compositions and methods to promote bone formation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3148517T3 true PL3148517T3 (pl) | 2021-11-29 |
Family
ID=54699759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15799544T PL3148517T3 (pl) | 2014-05-30 | 2015-05-28 | Kompozycje i sposoby do promowania tworzenia kości |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10208306B2 (pl) |
| EP (2) | EP3148517B1 (pl) |
| JP (2) | JP6920196B2 (pl) |
| CN (2) | CN106535880A (pl) |
| AU (3) | AU2015267006B2 (pl) |
| CA (1) | CA2984889C (pl) |
| DK (2) | DK3903772T3 (pl) |
| ES (2) | ES2881626T3 (pl) |
| HU (1) | HUE055062T2 (pl) |
| PL (1) | PL3148517T3 (pl) |
| PT (1) | PT3148517T (pl) |
| WO (1) | WO2015184059A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2881626T3 (es) * | 2014-05-30 | 2021-11-30 | Univ New York State Res Found | Composiciones y procedimientos para favorecer la formación ósea |
| CN109432504B (zh) * | 2018-11-27 | 2021-11-16 | 中国人民解放军总医院第四医学中心 | 一种成骨基因干预功能材料及其制备方法 |
| CN114364402A (zh) * | 2019-07-15 | 2022-04-15 | 罗瓦萨公司 | 用于治疗癌症的阿片类生长因子受体(ogfr)拮抗剂，特别是纳洛酮和/或纳曲酮 |
| JP7551339B2 (ja) * | 2020-06-04 | 2024-09-17 | 株式会社三共 | 遊技機 |
| JP7551341B2 (ja) * | 2020-06-04 | 2024-09-17 | 株式会社三共 | 遊技機 |
| EP4181981A4 (en) * | 2020-07-17 | 2024-08-21 | Zetagen Therapeutics, Inc. | METHODS AND COMPOSITIONS OF BONE GRAFT USING FERROUS EXCIPIENTS |
| KR20240147995A (ko) * | 2022-02-04 | 2024-10-10 | 김성진 | 뼈 및 연골을 제조하는 방법 |
| US11957676B1 (en) * | 2023-08-07 | 2024-04-16 | Zetagen Therapeutics, Inc. | Controlled release formulation and minimally invasive method of administration to locally treat cancer |
| US20250049784A1 (en) * | 2023-08-07 | 2025-02-13 | Zetagen Therapeutics, Inc. | Methods of treating prostate cancer or metastasized prostate cancer |
| US12403118B1 (en) | 2025-03-05 | 2025-09-02 | Zetagen Therapeutics, Inc. | Cancer treatments using modified fatty acids and the carriers to administer them |
| CN120209114B (zh) * | 2025-03-07 | 2026-04-07 | 首都医科大学 | 一种含有penk蛋白的组合物及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6270979B1 (en) | 1993-06-23 | 2001-08-07 | The Regents Of The University Of California | Methods for anti-addictive narcotic analgesic treatments |
| US6007986A (en) | 1993-06-23 | 1999-12-28 | The Regents Of The University Of California | Methods for anti-addictive narcotic analgesic activity screening |
| US5882944A (en) | 1993-06-23 | 1999-03-16 | The Regents Of The University Of California | Methods for G protein coupled receptor activity screening |
| JP2000509377A (ja) * | 1996-04-19 | 2000-07-25 | ザイモジェネティクス，インコーポレイティド | 骨形成を誘発するための方法 |
| US20010049375A1 (en) | 2000-03-15 | 2001-12-06 | Wolfgang Sadee | Neutral antagonists and use thereof in treating drug abuse |
| AU2001278943A1 (en) * | 2000-07-17 | 2002-01-30 | University Of Utah Research Foundation | Hydrogel films and methods of making and using therefor |
| US6949251B2 (en) * | 2001-03-02 | 2005-09-27 | Stryker Corporation | Porous β-tricalcium phosphate granules for regeneration of bone tissue |
| US7473678B2 (en) * | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
| US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
| US20070197573A1 (en) * | 2005-10-04 | 2007-08-23 | Wolfgang Sadee | Compositions and methods in the treatment of bone metabolic disorders |
| GB2463474B (en) * | 2008-09-11 | 2012-05-02 | Agency Science Tech & Res | Therapeutic bone growth and regeneration |
| US9511093B2 (en) | 2009-03-23 | 2016-12-06 | The Texas A & M University System | Compositions of mesenchymal stem cells to regenerate bone |
| US8529933B2 (en) * | 2009-07-27 | 2013-09-10 | Warsaw Orthopedic, Inc. | Biphasic calcium phosphate cement for drug delivery |
| EP2793961A4 (en) * | 2011-12-23 | 2015-06-24 | Skeletal Kinetics Llc | Porous calcium phosphate granule and process for its preparation and use |
| ES2881626T3 (es) * | 2014-05-30 | 2021-11-30 | Univ New York State Res Found | Composiciones y procedimientos para favorecer la formación ósea |
-
2015
- 2015-05-28 ES ES15799544T patent/ES2881626T3/es active Active
- 2015-05-28 ES ES21170355T patent/ES3041577T3/es active Active
- 2015-05-28 DK DK21170355.8T patent/DK3903772T3/da active
- 2015-05-28 CN CN201580041505.5A patent/CN106535880A/zh active Pending
- 2015-05-28 EP EP15799544.0A patent/EP3148517B1/en active Active
- 2015-05-28 CN CN202210831276.9A patent/CN116059376A/zh active Pending
- 2015-05-28 WO PCT/US2015/032820 patent/WO2015184059A1/en not_active Ceased
- 2015-05-28 DK DK15799544.0T patent/DK3148517T3/da active
- 2015-05-28 EP EP21170355.8A patent/EP3903772B1/en active Active
- 2015-05-28 JP JP2017515009A patent/JP6920196B2/ja active Active
- 2015-05-28 AU AU2015267006A patent/AU2015267006B2/en active Active
- 2015-05-28 PT PT157995440T patent/PT3148517T/pt unknown
- 2015-05-28 PL PL15799544T patent/PL3148517T3/pl unknown
- 2015-05-28 CA CA2984889A patent/CA2984889C/en active Active
- 2015-05-28 US US14/723,894 patent/US10208306B2/en active Active
- 2015-05-28 HU HUE15799544A patent/HUE055062T2/hu unknown
-
2018
- 2018-09-04 US US16/120,803 patent/US12258561B2/en active Active
-
2020
- 2020-02-20 JP JP2020026807A patent/JP6916918B2/ja active Active
- 2020-07-06 AU AU2020204496A patent/AU2020204496B2/en active Active
-
2022
- 2022-06-01 AU AU2022203758A patent/AU2022203758B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT3148517T (pt) | 2021-07-23 |
| EP3148517A1 (en) | 2017-04-05 |
| AU2022203758B2 (en) | 2024-02-15 |
| JP2017518369A (ja) | 2017-07-06 |
| AU2020204496B2 (en) | 2022-03-31 |
| US12258561B2 (en) | 2025-03-25 |
| WO2015184059A1 (en) | 2015-12-03 |
| JP6920196B2 (ja) | 2021-08-18 |
| US20190093109A1 (en) | 2019-03-28 |
| AU2022203758A1 (en) | 2022-06-23 |
| AU2015267006A1 (en) | 2016-12-08 |
| CA2984889A1 (en) | 2015-12-03 |
| AU2015267006B2 (en) | 2020-04-09 |
| EP3903772A1 (en) | 2021-11-03 |
| JP6916918B2 (ja) | 2021-08-11 |
| CA2984889C (en) | 2024-01-02 |
| CN106535880A (zh) | 2017-03-22 |
| US20150344882A1 (en) | 2015-12-03 |
| EP3148517A4 (en) | 2017-05-17 |
| DK3148517T3 (da) | 2021-07-26 |
| EP3903772B1 (en) | 2025-08-06 |
| HUE055062T2 (hu) | 2021-10-28 |
| JP2020097619A (ja) | 2020-06-25 |
| ES3041577T3 (en) | 2025-11-13 |
| ES2881626T3 (es) | 2021-11-30 |
| DK3903772T3 (da) | 2025-09-01 |
| US10208306B2 (en) | 2019-02-19 |
| AU2020204496A1 (en) | 2020-07-23 |
| CN116059376A (zh) | 2023-05-05 |
| EP3148517B1 (en) | 2021-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287789A (en) | Mogroside compounds, methods for their preparation, preparations including them and their uses | |
| GB2535253B (en) | Compositions and methods | |
| ZA201701244B (en) | Carrier-antibody compositions and methods of making and using the same | |
| IL249011B (en) | Methods and preparations related to exosomes | |
| ZA201607540B (en) | Compositions and methods to treating hemoglobinopathies | |
| ZA201702794B (en) | Cellulose-containing compositions and methods of making same | |
| HUE056172T2 (hu) | Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra | |
| GB2541833B (en) | Improvements to implant surfaces | |
| PT3148517T (pt) | Composições e métodos para promover a formação óssea | |
| GB201417828D0 (en) | New methods and compositions | |
| IL246879A0 (en) | Preparations of Epilimod and methods of using them | |
| IL248044B (en) | Oligonucleotide preparations and methods for their preparation | |
| PL3113774T3 (pl) | Kompozycje grapiprantu i sposoby ich zastosowania | |
| IL246711A0 (en) | Biologically active haloperoxidase compositions and methods of using them | |
| IL251238B (en) | Mineral-based compounds and their uses | |
| GB201402915D0 (en) | Compositions and methods | |
| PL3131633T3 (pl) | Pochodne MMF etylenoglikoli | |
| GB201403212D0 (en) | Compositions and methods | |
| GB201419559D0 (en) | Therapeutic compositions and methods | |
| GB201415759D0 (en) | Accelerator compositions and methods | |
| GB201418410D0 (en) | use of compositions of matter | |
| GB201412359D0 (en) | Composition of objects | |
| GB201412089D0 (en) | Composition of objects |